These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 18787222

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.
    Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O'Byrne PM.
    N Engl J Med; 2009 Mar 05; 360(10):985-93. PubMed ID: 19264687
    [Abstract] [Full Text] [Related]

  • 24. Treatment of epidermolysis bullosa acquisita with the humanized anti-Tac mAb daclizumab.
    Egan CA, Brown M, White JD, Yancey KB.
    Clin Immunol; 2001 Nov 05; 101(2):146-51. PubMed ID: 11683573
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The fractional excretion of soluble interleukin-2 receptor-alpha is an excellent predictor of the interleukin-2 receptor-alpha status after treatment with daclizumab.
    ter Meulen CG, Jacobs CW, Wetzels JF, Klasen IS, Hilbrands LB, Hoitsma AJ.
    Transplantation; 2004 Jan 27; 77(2):281-6. PubMed ID: 14742994
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study.
    Kips JC, O'Connor BJ, Langley SJ, Woodcock A, Kerstjens HA, Postma DS, Danzig M, Cuss F, Pauwels RA.
    Am J Respir Crit Care Med; 2003 Jun 15; 167(12):1655-9. PubMed ID: 12649124
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series.
    Nussenblatt RB, Peterson JS, Foster CS, Rao NA, See RF, Letko E, Buggage RR.
    Ophthalmology; 2005 May 15; 112(5):764-70. PubMed ID: 15878055
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthma.
    Berger W, Gupta N, McAlary M, Fowler-Taylor A.
    Ann Allergy Asthma Immunol; 2003 Aug 15; 91(2):182-8. PubMed ID: 12952113
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of soluble IL-4 receptor for the treatment of adults with asthma.
    Borish LC, Nelson HS, Corren J, Bensch G, Busse WW, Whitmore JB, Agosti JM, IL-4R Asthma Study Group.
    J Allergy Clin Immunol; 2001 Jun 15; 107(6):963-70. PubMed ID: 11398072
    [Abstract] [Full Text] [Related]

  • 38. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA, Pudi KK, Zvarich MT, Sanford L, Siederer SK, Crim C.
    Clin Ther; 2012 Aug 15; 34(8):1655-66.e5. PubMed ID: 22789766
    [Abstract] [Full Text] [Related]

  • 39. Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids.
    Noonan M, Korenblat P, Mosesova S, Scheerens H, Arron JR, Zheng Y, Putnam WS, Parsey MV, Bohen SP, Matthews JG.
    J Allergy Clin Immunol; 2013 Sep 15; 132(3):567-574.e12. PubMed ID: 23726041
    [Abstract] [Full Text] [Related]

  • 40. Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial.
    Borish LC, Nelson HS, Lanz MJ, Claussen L, Whitmore JB, Agosti JM, Garrison L.
    Am J Respir Crit Care Med; 1999 Dec 15; 160(6):1816-23. PubMed ID: 10588591
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.